Bisoprolol Fumarate Tablet, Film Coated
FDA Label NDC 70771-1727

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Bisoprolol Fumarate (NDC 70771-1727). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1726-3

Bisoprolol Fumarate Tablets USP, 5 mg

30 Tablets

Unit-of-Use

Rx only

5 mg Label (Bd36cf67 11ab 4a1f B1b6 9d5c078a9206 01)

5 mg Label (Bd36cf67 11ab 4a1f B1b6 9d5c078a9206 01)

NDC 70771-1727-3

Bisoprolol Fumarate Tablets USP, 10 mg

30 Tablets

Unit-of-Use

Rx only

10 mg Label (Bd36cf67 11ab 4a1f B1b6 9d5c078a9206 02)

10 mg Label (Bd36cf67 11ab 4a1f B1b6 9d5c078a9206 02)

* Please review the disclaimer below.